infectious-diseases

Documents about infectious-diseases

• Treatment With hOKT3gamma1(Ala-Ala) in T1DM#245423ClinicalTrials.gov
• POS-cUTI: Study on Complicated Urinary Tract Infections#245532ClinicalTrials.gov
• Scalable deep-learning-based inference of time-varying transmission dynamics from outbreak phylogenies#266320bioRxiv / medRxiv
• Intravenous Fosfomycin Pharmacokinetics Study#268065ClinicalTrials.gov
• A Phase 1 Trial to Evaluate CAP256V2LS in Healthy Adults#303592ClinicalTrials.gov
• ACTIV-2: A Study for Outpatients With COVID-19#311166ClinicalTrials.gov
• Safety and Immunogenicity of CJCV2 With and Without ALFQ#325137ClinicalTrials.gov
• "Prime-Boost" Vaccine Schedule for Prevention of HIV Infection#353321ClinicalTrials.gov
• Podcast: Immune Persistence After Primary Vaccination with MenQuadfi#355783Springer Nature OA
• Multicountry validation of a proteomic host-response signature associated with tuberculosis disease severity#390874bioRxiv / medRxiv
• Wearable Technologies for Vaccines and Therapeutics in Infectious Diseases: A Scoping Review#445486Europe PMC
• 42 U.S.C. § 247d-4a — Infectious Diseases Rapid Response Reserve Fund#595399US Code (LII)
• Tulane virus protease as a structural surrogate for inhibitor screening of human norovirus proteases#612279eScholarship
• PvGAP: Development of a globally-applicable, highly-multiplexed microhaplotype amplicon panel for Plasmodium vivax#10137bioRxiv / medRxiv
• A Multi-Omics Study Reveals Pathway-Level Insights and Predictive Biomarkers in Pediatric TB#10170bioRxiv / medRxiv
• Protocol for DNA Extraction from QuantiFERON-TB Gold Tubes for PCR and Sequencing Applications#13926bioRxiv / medRxiv
• Centralizing EU Policy in Fighting Infectious Diseases: Status Quo, Citizen Preferences, and Ways Forward#17069EconStor
• A systematic review of Nipah virus disease epidemiological parameters, outbreaks and mathematical models#28606bioRxiv / medRxiv
• First evidence of zoonotic spillover of MERS-CoV into occupationally exposed populations in Somalia#67994bioRxiv / medRxiv
• An overview of the reclassification of COVID-19 of the Infectious Diseases Control Law in Japan#69468J-STAGE (Japan)
• Immune Responses to Two Dose Varivax +/- MMR-II#141082ClinicalTrials.gov
• Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)#143618ClinicalTrials.gov
• Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)#160411ClinicalTrials.gov
• Methods for estimating the burden of acute tropical infectious diseases: A scoping review.#174541NCBI PubMed Central
• Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)#181762ClinicalTrials.gov
• Dried Blood Spot Testing of CMV Detection in HCT Recipients#184916ClinicalTrials.gov
• One Health genomics of Acinetobacter baumannii reveals sector-specific lineages and permeable ecological barriers#200196bioRxiv / medRxiv
• Probiogenomic insights into Bacillus velezensis MFSS1 for controlling aquaculture pathogens#201299Universiti Putra Malaysia Institutional Repository
• Phase I Study of Vaccination Schedule of Experimental HIV Vaccines#208252ClinicalTrials.gov
• Group A Streptococcus Molecular Point of Care testing in a Paediatric Emergency Department#214806bioRxiv / medRxiv
• Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections#268034ClinicalTrials.gov
• Research Study of ATG and Rituximab in Renal Transplantation#272459ClinicalTrials.gov
• Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients#279578ClinicalTrials.gov
• Analysis Of Salivary Herpesviruses Reveals Associations Between HHV-6 And Long COVID Severity#293991bioRxiv / medRxiv
• DAMPA - accelerated and simplified design of probe panels for targeted metagenomics using pangenome graphs#296525bioRxiv / medRxiv
• HIV-1 Vaccine Test in Uninfected Adult Volunteers#300319ClinicalTrials.gov
• A Market-Based Virus Monitoring Strategy Complementary to Epidemiological Surveillance in Urban Settings#307239bioRxiv / medRxiv
• Multiplexed Isothermal Nucleic Acid Detection Using Sequence-Specific Cleavage Mediated by Repair Endonucleases#329350bioRxiv / medRxiv
• Interplay Between Infectious Diseases and the Endocrine System: An Overview and Clinical Insights.#340370NCBI PubMed Central
• Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients#366631ClinicalTrials.gov
• Leveraging the HIV Platform for Hypertension Control in Uganda (INTEGRATED HIV/HTN) STUDY#390985ClinicalTrials.gov
• Wastewater-Based Epidemiology for Infectious Diseases: A New Trick for an Old Threat.#392733NCBI PubMed Central
• Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults#394613ClinicalTrials.gov
• Serotype skewing and immune imprinting shape response to the tetravalent dengue virus Qdenga vaccine#401694bioRxiv / medRxiv
• Flublok or Fluzone With Advax-CpG55.2 or AF03#405206ClinicalTrials.gov
• Anti-HBsAg antibody mAb19-LS enhances antiviral immunity in humans with chronic hepatitis B#424137bioRxiv / medRxiv
• Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis#435757ClinicalTrials.gov
• Municipal wastewater surveillance reveals socioeconomic and immigration gradients in antimicrobial resistance across Alberta, Canada#467682bioRxiv / medRxiv
• 25 U.S.C. § 1621q — Prevention, control, and elimination of communicable and infectious diseases#582480US Code (LII)
• The gammaherpesviral TATA-box-binding protein directly interacts with the CTD of host RNA Pol II to direct late gene transcription#609406eScholarship